Fact-checked by Grok 2 weeks ago

John Abele

John E. Abele (born 1937 in ) is an American businessman, inventor, and philanthropist best known as the co-founder of Corporation, a leading medical technology company specializing in minimally invasive devices for treating cardiovascular, endoscopic, and other conditions. Abele's career began after earning a B.A. in physics and philosophy from in 1959, where he later served as a from 1997 to 2003 and established for Community Engagement in 2007. Early in his professional life, he worked in sales, technical, and general management roles at Advanced Instruments, Inc., before acquiring an equity interest in Medi-tech, Inc., in the late —a firm focused on innovative medical tools. He served as president of Medi-tech from 1970 to 1983, during which time he pioneered technologies like balloons that revolutionized less-invasive procedures. In 1979, Abele co-founded with Peter Nicholas, initially as a for Medi-tech, with the mission to develop accessible, minimally invasive medical treatments; he took the company public in 1992, growing it into a global enterprise with approximately 53,000 employees (as of 2024) and inclusion on the list. At the company, he held key leadership positions, including from 1979 to 1992, co-chairman from 1979 to 1995, vice chairman of the Office of the Chairman from 1995 to 1996, and until his retirement from the board in 2011, after which he served as director emeritus until 2017. Abele holds multiple patents in technology, has published extensively on in healthcare, and lectured worldwide on the topic; his work contributed to breakthroughs such as paclitaxel-eluting stents. Beyond business, Abele is a prominent philanthropist through his family’s Argosy Foundation, which has donated over $130 million since 2001 to support , scientific research, , and community initiatives, including funding a 2007 expedition to locate the WWII submarine sunk by his father's command in 1942. He also founded the Kingbridge Conference Centre and Institute in , , a venue for collaborative dialogue on global issues, and serves as chairman of the F.I.R.S.T. ( for Innovation and Research in Science and Technology) board. His contributions to medical have earned him numerous accolades, including the 2015 Medical Design Excellence Awards (MDEA) Lifetime Achievement Award, the 2015 TCT Achievement Award, the 2016 AdvaMed Lifetime Achievement Award (co-recipient with Peter Nicholas), and the 2020 Society of (SIR) Leaders in Innovation Award.

Early life and education

Early life

John Abele was born on February 2, 1937, in , as the youngest of three sons in a classic family. His parents were Catherine "Kay" Eaton Abele and Lieutenant Commander Mannert Lincoln Abele, a U.S. Navy officer who commanded the submarine USS Grunion during . In May 1942, when Abele was five years old, his father departed on the Grunion's first war patrol from New London, and the vessel was lost with all hands on July 31 near in the , presumed sunk by enemy action. Following the loss, Abele's mother, Kay, raised the three boys alone in and later , where she became a teacher and purchased a modest $3,000 home. She instilled values of and in the family, rejecting a benefit because she believed her husband was missing rather than dead, and even wrote condolence letters to the Grunion crew's relatives. Decades later, in 2005–2007, Abele joined his brothers and in funding and leading the Lost 52 Project's expeditions, which located and imaged the Grunion's wreck at a depth of about 3,000 feet off , providing closure to the family's long-standing mystery. At age seven, around 1944, Abele contracted , a severe bacterial that necessitated multiple surgeries, extended hospital stays, and years of using crutches for mobility. These experiences in medical environments ignited his early fascination with medical devices and gadgets, as he observed and pondered the tools used in his treatment. Despite the challenges, Abele adapted by viewing his condition as a competitive edge, eventually outpacing his peers on crutches. As a young boy, Abele displayed a precocious talent for invention and tinkering, building mechanical devices such as radios, a homemade , a , an aqualung, a pneumatic , and even an fashioned from a with a fan-blade . These formative pursuits in his family's supportive yet frugal household laid the groundwork for his later innovations. He later transitioned to formal education, attending .

Education

John Abele attended Amherst College, graduating in 1959 with a Bachelor of Arts degree, having double-majored in physics and philosophy. At Amherst, Abele's studies in physics introduced him to rigorous scientific inquiry and quantitative problem-solving methods, laying a technical groundwork that would prove essential in his later work with complex medical technologies. His concurrent pursuit of philosophy exposed him to ethical frameworks and human-centered perspectives, fostering a deep curiosity about organizational behavior and the societal roles of innovation. These interdisciplinary influences encouraged Abele to view technological advancements not merely as engineering feats but as tools requiring ethical consideration and collaborative application. Reflecting on his education after graduation, Abele credited with providing the analytical foundation for tackling challenges, while honed his ability to assess technology's broader impacts on communities and human well-being. This blend of disciplines shaped his lifelong commitment to innovations that prioritize both efficacy and ethical responsibility in healthcare.

Career

Early career

Following his graduation from Amherst College in 1959 with degrees in physics and , John Abele joined Advanced Instruments, Inc., a family-owned company specializing in laboratory analytical . He began in sales roles, promoting devices such as osmometers—which measured particle concentrations in solutions for medical and biological applications—and flame photometers, which analyzed ion levels in fluids, often used in clinical for testing. These instruments provided Abele with early exposure to healthcare technology, where his physics background enabled him to bridge technical explanations with practical user needs in scientific and medical settings. Over the mid-1960s, Abele advanced into and general positions at Advanced Instruments, rising to the of manager. In these capacities, he handled , product demonstrations, and collaborative problem-solving, such as inviting physicians and researchers to the company's facilities to test and refine equipment on-site. This hands-on involvement honed his understanding of requirements for precise, user-friendly tools in diagnostic processes, emphasizing communication between engineers and end-users. His experiences also influenced innovative approaches, drawing from interactions with figures like Jack , who demonstrated the value of immersive . By 1965, Abele departed Advanced Instruments due to limited opportunities for ownership in the family business. In the subsequent years, he explored the burgeoning medical device sector, co-founding the Association for the Advancement of Medical Instrumentation (AAMI) in 1965 to foster standards, education, and interdisciplinary dialogue among doctors, engineers, and manufacturers. This period marked his growing involvement with emerging medical technology ventures in the late 1960s, building on his foundational skills in instrument sales and support.

Medi-Tech and pre-Boston Scientific work

In 1969, John Abele joined Medi-Tech, Inc., a small firm founded by inventor in the late and initially operating out of a church basement in . Prior to this role, Abele had gained sales experience at Advanced Instruments, Inc. Abele became president of Medi-Tech from 1970 to 1983, during which he oversaw the company's transformation from a modest research and development operation with limited monthly revenue of around $5,000 into a pioneer in catheter technologies. Under his leadership, Medi-Tech exercised expansion strategies centered on product diversification and equity acquisition, including Abele's own buy-in of the company in 1970, to build a platform around catheter-based innovations. These efforts emphasized the development of interventional cardiology tools designed to enable minimally invasive procedures and reduce surgical trauma, such as steerable multilumen catheters for vascular and gastrointestinal applications. Abele's tenure featured close collaboration with Bentov on early prototypes, including steerable catheters co-developed with physicians from Beth Israel Hospital, which laid the groundwork for less-invasive diagnostic and therapeutic devices. This partnership focused on innovations like steerable tips and softer catheter materials to improve in arteries, veins, and urological pathways, fostering the growth of in the 1970s. Throughout the 1970s, Medi-Tech encountered significant challenges, including constrained funding that limited scaling efforts and a lack of initial acceptance from surgeons skeptical of catheter-based alternatives to open surgery. Regulatory hurdles further complicated operations, as the field operated without formal oversight until the Medical Device Amendments of 1976 introduced FDA classification and approval processes, shifting development toward more bureaucratic compliance. Despite these obstacles, Abele relied on champions and early adopters to drive incremental progress in the nascent medtech landscape.

Founding and leadership at Boston Scientific

In 1979, John Abele co-founded Corporation with Peter Nicholas in , initially establishing it as a to acquire and distribute products from Medi-Tech, Inc., a firm where Abele had previously held an equity interest. Building on Medi-Tech's early innovations in minimally invasive tools, transitioned into manufacturing and marketing its own devices, focusing on advancing less-invasive medical procedures to improve patient care. The company started with fewer than 50 employees and limited financing, but Abele's vision for scalable medical technologies laid the foundation for rapid growth. Abele served as treasurer from 1979 to 1992 and co-chairman from 1979 to 1995, playing a pivotal role in steering the company's financial and strategic direction. Under his leadership, went public in 1992 through an on the , which provided capital for expansion and marked a turning point in its development as a major player in the medical device industry. He also guided key acquisitions, such as the 1994 merger with SCIMED Life Systems, a Minnesota-based pioneer in cardiovascular technologies, which doubled the company's size and strengthened its portfolio in and related fields. These moves exemplified Abele's approach to strategic partnerships that accelerated innovation and . The company's strategic emphasis on minimally invasive technologies drove significant milestones, with early revenues primarily from products that enabled precise, less traumatic interventions. Boston Scientific expanded into with stents and balloons, for gastrointestinal procedures, and for and neurological conditions, transforming treatment paradigms across specialties. By the mid-2000s, these efforts had propelled the company to global leadership, employing over 25,000 people worldwide and generating billions in annual revenue. Abele retired as an active executive in 1995 but continued serving on the , providing ongoing guidance until 2011, after which he served as director emeritus until 2017. Abele's business philosophy centered on fostering collaboration among engineers, clinicians, and executives to develop technologies that reduce procedural risks, trauma, costs, and time while prioritizing positive patient outcomes. This patient-focused ethos, rooted in ethical innovation and cross-disciplinary teamwork, became a core tenet of Scientific's culture, enabling the company to pioneer procedures that minimized surgical invasiveness and enhanced recovery. His leadership emphasized sustainable growth through calculated risks and a commitment to improving healthcare delivery globally.

Inventions and innovations

In the 1970s, John Abele co-developed the at Medi-Tech, a device featuring internal wires that allowed precise control and navigation through blood vessels, revolutionizing procedures like and vascular diagnostics. This innovation, initially created in collaboration with inventor , enabled physicians to maneuver catheters with greater accuracy, reducing the need for open surgery in cardiovascular interventions. Abele holds numerous patents—more than 40 in total—focused on , balloon s, and endoscopic tools, including designs for steerable guidewires (e.g., U.S. No. 5,385,152) and deflectable sheaths that improved device delivery and maneuverability during minimally invasive procedures. These inventions addressed key challenges in flexibility and control, such as incorporating radiopaque markers for better and resilient tips for penetrating arterial occlusions. Abele played a pioneering role in by adapting steerable technology for percutaneous transluminal (PTCA), collaborating with in the mid-1970s to refine multi-lumen designs that facilitated balloon dilatation of narrowed . His contributions helped establish PTCA as a standard treatment, shifting from invasive surgeries to -based interventions that restored blood flow with minimal incision. From the 1970s onward, Abele authored influential publications and delivered lectures on technology, the social implications of innovation, and techniques for less-invasive surgery, including the seminal paper "Balloon Catheters and Transluminal Dilatation: Technical Considerations," which detailed the physics and engineering principles behind safe balloon deployment. His talks, often at medical conferences, emphasized ethical considerations in technology adoption and the potential for devices to democratize access to advanced care. Abele's advancements have had a profound broader impact, significantly reducing procedure times, healthcare costs, and patient trauma while setting global standards in and extending to fields like and through enhanced endoscopic capabilities. By enabling outpatient treatments and lowering complication rates, these innovations have improved outcomes for millions, fostering the growth of minimally invasive medicine worldwide.

Personal life

Family

John Abele married Abele (February 14, 1938 – October 11, 2025) in 1964, forming a partnership that lasted until her death in October 2025. The couple shared a home in , where they raised their family while prioritizing a private life away from public scrutiny. Abele and Mary had three children: Christopher (born January 28, 1967), who served as from 2011 to 2020; , a ; and Jennifer (also known as Jeneye), who serves as President and CEO of the Argosy Foundation. The family emphasized education, with all three children attending in . Throughout their years in , the Abeles maintained a close-knit household focused on supporting their children's personal and professional growth, fostering values of and that echoed Abele's own upbringing. This environment of privacy allowed the family to navigate successes and challenges together, including Mary's role as a devoted and .

Philanthropy

John Abele established the Argosy Foundation in 1997 as a private family philanthropy to support initiatives in , , , and . Since 2001, the foundation has donated more than $130 million to a range of charitable causes, reflecting Abele's commitment to fostering innovation and community well-being enabled by his success at . The foundation prioritizes partnerships that enhance learning and systemic change in these areas, with giving extending nationally. A of Abele's promoting education among youth. He served as chairman of the FIRST (For Inspiration and Recognition of Science and Technology) Foundation from 2002 to 2010, helping expand its robotics competitions to inspire hands-on learning and build corporate and academic networks. Under his leadership, FIRST grew into an international program engaging high school students in engineering challenges to develop problem-solving skills. Abele has made significant contributions to higher education through the Argosy Foundation. In 2006, it awarded Amherst College—an institution where Abele earned his B.A. in physics and —a seven-year, $13 million grant to create the Center for Community Engagement. This funding supported student internships in , focusing on issues like , , , , and , while building ties with community organizations. Abele also served as a trustee of , further aligning his giving with educational access and civic involvement. In support of medical research and collaborative innovation, Abele founded the Kingbridge Centre in King City, Ontario, in 2001 as a conference facility and institute dedicated to advancing dialogue on conflict resolution, interdisciplinary collaboration, and knowledge sharing. The center, designed to host events fostering ethical innovation and global problem-solving, embodies Abele's vision for "full-profit philanthropy" that generates social returns alongside financial sustainability. Abele's giving extends to arts organizations and environmental conservation, particularly in Vermont, where he resides. The Argosy Foundation has provided substantial support to cultural institutions in the state, enhancing community arts programs and access. Environmentally, he has aided , a nonprofit educational promoting and economic literacy through visitor programs and conservation efforts. His son, Chris Abele, has played a central role in the foundation's operations as a former CEO, extending family involvement in these initiatives.

Net worth and legacy

As of November 2025, John Abele's net worth is estimated at $2 billion, primarily stemming from his substantial holdings in Corporation stock. He first appeared on the list in 1996, marking his recognition as a self-made following the company's public offering in 1992. Residing in , Abele holds the distinction of being the state's only , with his fortune directly linked to pioneering advancements in medical technology that revolutionized patient care. Abele's legacy endures as a foundational figure in minimally invasive medicine, where his leadership at Boston Scientific transformed interventional procedures by introducing less traumatic technologies that improved outcomes and accessibility worldwide. His visionary approach has inspired global medtech entrepreneurship, fostering a culture of innovation that emphasizes ethical development and collaborative problem-solving in healthcare. Through lectures and writings, Abele has emphasized the ethics of technological innovation and the value of interdisciplinary collaboration in scientific progress, with his 1996 Forbes listing serving as a milestone in his ascent as an industry leader. In 2015, Abele received the TCT Career Achievement Award from the Cardiovascular Research Foundation, honoring his profound and lasting contributions to less invasive medicine and . He maintains ongoing influence through board roles, including as director emeritus of , where he continues to guide strategic directions in medtech. A portion of his wealth supports philanthropic initiatives focused on education and community health.

References

  1. [1]
    John Abele '59 | 2011 Honorees - Amherst College
    Abele co-founded Boston Scientific with Peter Nicholas in 1979, with the goal of developing technologies to make medical procedures less invasive and more ...Missing: biography | Show results with:biography
  2. [2]
    John Abele & family - Forbes
    John Abele cofounded medical device developer Boston Scientific in 1979 to provide less invasive, more accessible treatments. Abele took the company public ...
  3. [3]
    John E. Abele | GBH - WGBH
    John Abele is the co-founder and a director of Boston Scientific since 1979. Mr. Abele was the treasurer from 1979 to 1992, co-chairman from 1979 to 1995.Missing: biography | Show results with:biography
  4. [4]
    [PDF] We are advancing science for life.
    Our history began in the late 1960s when our co-founder, John. Abele, acquired an equity interest in Medi-tech, Inc., a research and development company ...Missing: biography | Show results with:biography
  5. [5]
    [PDF] Proxy Statement - Boston Scientific Investor Relations
    Mar 22, 2016 · John E. Abele, our co-founder, has served at the request of the Board as director emeritus since his retirement from the Board at the 2011 ...
  6. [6]
    John Abele, Co-Founder of Boston Scientific, Honored for Lifetime ...
    Jun 4, 2015 · PRNewswire/ -- John Abele, will receive the Medical Design Excellence Awards (MDEA) 2015 Lifetime Achievement Award during its annual ...<|separator|>
  7. [7]
    Boston Scientific Co-founder John Abele Recognized by TCT ...
    Oct 12, 2015 · John Abele, long respected for his contributions to the medical industry, received the TCT 2015 Career Achievement Award on Monday in the Main Arena.
  8. [8]
    Lifetime Achievement Award - AdvaMed®
    Philanthropy, community service, community leadership. Previous ... John Abele, 2016 Co-Recipient. Peter Nicholas, 2016 Co-Recipient.
  9. [9]
    2009: Spring Feature: Flowers on the Water - Amherst College
    The Abele and Eaton families were “classic Yankee types,” John Abele recalls. Self-pity was not on the program. At 7, John was stricken with osteomyelitis ...
  10. [10]
    Vermont's only billionaire overcame death of father in WWII ...
    Apr 16, 2024 · Abele was raised in a “Classic Yankee family,” the youngest of three sons of Catherine (née Eaton) and Lieutenant Commander Mannert Lincoln ...Missing: background | Show results with:background
  11. [11]
    Mannert Abele (U.S. National Park Service)
    Jul 18, 2025 · Mannert “Jim” Lincoln Abele enlisted in the Navy at 17, in 1920 as an Apprentice Seaman. He rose through the ranks and eventually became Lieutenant Commander ...
  12. [12]
    Grunion (SS-216) - Naval History and Heritage Command
    Nov 22, 2019 · Cmdr. Mannert L. Abele in command, Grunion began her post-commissioning work-up in the waters off New London on 13 April 1942. The boat ...<|control11|><|separator|>
  13. [13]
    Grunion-Expedition--06 - Lost 52 Project
    ... Abele brothers initiated a search for the USS Grunion, their dad's sub, lost since 1942. ... John performed a small memorial ceremony with flowers from Kiska.
  14. [14]
    USS Grunion (U.S. National Park Service)
    Jul 18, 2025 · The USS Grunion was a Gato-class submarine, laid down in 1941 and commissioned in 1942 with Lieutenant Commander Mannert “Jim” Abele in charge.
  15. [15]
    [PDF] John E. Abele - ASME
    Abele earned his bachelor's degree in physics and philosophy at Amherst College in 1959. He received honorary doctorates from. Northeastern University and Went-.<|control11|><|separator|>
  16. [16]
    Growth Through Collaboration: John Abele's Vision - Korn Ferry
    Nov 17, 2013 · As cofounder of Boston Scientific, the medical devices giant, Abele helped pioneer and foster the concept of minimally invasive surgery. Along ...
  17. [17]
    John Abele: Always an Educator
    May 5, 2015 · John Abele: Always an Educator. The 2015 MDEA Lifetime ... Soon after the Amherst College physics and philosophy double major ...
  18. [18]
    John E. Abele COF-0001 - AIMBE
    Soon after the Amherst College physics and philosophy double major started working in medical sales in 1960, he found himself drawn to the problem-solving ...
  19. [19]
    Boston Scientific Cofounder John Abele Has Big Ambitions ... - Forbes
    Jun 18, 2014 · Since retiring from Boston Scientific in 2005, the now 77-year-old Abele has engaged in a busy second career of philanthropy, venture investing and tinkering.Missing: childhood | Show results with:childhood
  20. [20]
    Association for the Advancement of Medical Instrumentation ...
    Dr. John Merrill of Peter Bent Brigham Hospital, and John Abele, Sales Manager of Advanced Instruments, Inc. joined with Hall and Allen to establish AAMI. Among ...
  21. [21]
    The Makings of a Medtech Pioneer: John Abele
    In recent years, Abele has won numerous awards including the 2015 MDEA Lifetime Achievement Award.
  22. [22]
    Boston Scientific's beginning, through John Abele's eyes
    Jun 9, 2010 · He was actually born in Czechoslovakia, parents wiped out by the Nazis, emigrated to Palestine, later Israel, and wound up speaking something ...
  23. [23]
    John Abele - Big Think
    John E. Abele has been a director of Boston Scientific since 1979. Mr. Abele was the Treasurer from 1979 to 1992, Co-Chairman from 1979 to 1995 and Vice ...
  24. [24]
    [PDF] FORM DEF 14A - Boston Scientific Investor Relations
    Mar 19, 2008 · He was President of Medi-tech, Inc. from 1970 to 1983, and prior to ... John Abele are not independent because they were employees of ...<|control11|><|separator|>
  25. [25]
    https://investors.bostonscientific.com/~/media/Files/B/Boston-Scientific-IR-V3/annual-reports-proxy-statements/2008-Proxy-Statement.pdf
  26. [26]
    Boston Scientific Corporation - Company-Histories.com
    Boston Scientific Corporation was founded in 1979 by John Abele and Peter Nicholas, who met while watching their children play soccer. Nicholas, a Wharton ...
  27. [27]
    [PDF] Boston Scientific Corporation
    Mar 18, 2009 · John Abele, our co-founder, has been a Director of Boston Scientific ... He was President of Medi-tech, Inc. from 1970 to 1983, and ...
  28. [28]
    History of Boston Scientific Corporation – FundingUniverse
    Boston Scientific is founded by John Abele and Peter Nicholas for the purpose of acquiring Medi-Tech, Inc. 1992: Boston Scientific makes first public stock ...
  29. [29]
    2 Medical Companies To Merge - The New York Times
    Nov 9, 1994 · Nicholas and John E. Abele, the co-founders of Boston Scientific, were among the majority shareholders approving the deal. The company has been ...
  30. [30]
    Boston Scientific begins layoffs announced in February - MPR News
    Apr 14, 2011 · Boston Scientific, which employs some 5000 Minnesotans, is laying off ... At the end of last year, the company had about 25,000 employees.
  31. [31]
    [PDF] printmgr file - Boston Scientific Investor Relations
    Oct 31, 2013 · Our history began in the late 1960s when our co-founder, John. Abele, acquired an equity interest in Medi-tech, Inc., a research ... non- ...
  32. [32]
    MassDevice Q&A: Boston Scientific co-founder John Abele
    Jun 9, 2010 · Abele told MassDevice about Boston Scientific's connection with Bentov and his Belmont, Mass.-based lab, why his invention was so revolutionary and how the ...Missing: osteomyelitis | Show results with:osteomyelitis
  33. [33]
    [PDF] B OSTON S CIENTIFIC A NNUAL R EPORT 2004
    Joe joined Boston Scientific in 1983 as President of Medi-tech, Inc., and over the years held a number of executive leadership positions within the Company. We ...
  34. [34]
    John Abele: Full-profit philanthropy for healthy communities
    Nov 8, 2010 · ” Abele received his bachelor's degree from Amherst College, where he is now a trustee emeritus. Abele spoke with Faith & Leadership about ...
  35. [35]
    John E. Abele Inventions, Patents and Patent Applications - Justia ...
    Patent number: 5704913 · Abstract: A catheter for insertion into a bodily conduit, especially an artery. · Type: Grant · Filed: May 19, 1994 · Date of Patent: ...
  36. [36]
    Angioplasty / PTCA Interview - Abele, Part 1
    John E. Abele, Founder Chairman of Boston Scientific Corporation, began his involvement with the field of minimally invasive medicine over three decades ago ...
  37. [37]
    Health reform and technology--what does it mean for us? - PubMed
    Boston Scientific's roots trace back to 1969, when Abele joined with Itzhak Bentov to build a company around a steerable catheter. The associated technology ...Missing: Medi- history
  38. [38]
    MARY ABELE Obituary (1938 - 2025-10-11) - Shelburne, MA - Legacy
    Oct 17, 2025 · She will be deeply missed by her husband, John; her children, Chris (Jen), Alex (Heather), and Jeneye (Eric); and her eleven grandchildren ...
  39. [39]
    Christopher S Abele, Milwaukee Public Records Instantly - Clustrmaps
    Quick Facts. 01.28.67 is the birth date of Christopher. Christopher's age is 58. Eight alternative names are known: Chris Abele, Christopher A Abele, ...
  40. [40]
    Alexander T. Abele | Activist Facts
    Classical music composer; Son of John E. Abele.
  41. [41]
    Argosy Foundation - Who We Are
    The Argosy Foundation is a private family foundation founded in 1997 by John Abele, co-founder of Boston Scientific.What We Do · Contact · Partner Stories · UpdatesMissing: residence | Show results with:residence
  42. [42]
    John Abele - Concord Academy
    John is co-founder of Boston Scientific, a medical device company with more than 25,000 employees, and was president of Medi-tech, Inc. He retired from Boston ...Missing: biography | Show results with:biography
  43. [43]
    The Billionaire's Son - Milwaukee Magazine
    Feb 1, 2005 · Unlike Nicholas, who doled out charitable gifts in large lump sums, including $72 million to Duke University, John Abele proceeded slowly.
  44. [44]
    Obituary: Mary Abele, 1938-2025 - Seven Days
    Oct 17, 2025 · Born in Boston and raised in Concord, Mass., Mary attended Concord Academy, Winsor School, Wellesley and Boston University, where she made ...<|control11|><|separator|>
  45. [45]
    Argosy Foundation | Inside Philanthropy
    Oct 25, 2024 · The Argosy Foundation supports education, health, human services, environmental causes and the arts. Giving is national in scope.
  46. [46]
    FIRST Leadership - FIRST Robotics
    As an inventor, he holds more than 1,000 U.S. and foreign patents, many of them for innovative medical devices that have expanded the frontiers of healthcare ...
  47. [47]
    Amherst College Receives $13 Million From Argosy Foundation
    Abele, a 1959 graduate of Amherst College, where he majored in physics and philosophy. Abele was the founding chairman of Boston Scientific Corporation, a ...Missing: degrees | Show results with:degrees
  48. [48]
    The Kingbridge Centre Changes Ownership And Expands Business ...
    Mar 23, 2022 · [King Township, York Region March 3, 2021] – Founded in 2001 by John Abele, cofounder of Boston Scientific and a global leader in the field ...
  49. [49]
    involvement section - CURB magazine
    Although John Abele started the foundation, his ... The foundation has donated heavily in both Boulder, Colorado, and throughout Vermont ... Arts. Chris ...
  50. [50]
    Chris Abele - Ballotpedia
    Abele is the son of billionaire John Abele, the co-founder of the Boston Scientific medical device company. On October 16, 2019, Abele announced he would not ...
  51. [51]
    How many billionaires are from Vermont? Only one, per Forbes list
    Apr 16, 2024 · John Abele, co-founder of Boston Scientific, is Vermont's lone billionaire. He lives in Shelburne and a net worth of $1.9 billion, according to Forbes.
  52. [52]
    John Abele, a pioneer of minimally invasive medicine, tells grads to ...
    Jun 17, 2015 · He is widely regarded as a pioneer in the field of minimally invasive medicine, which has profoundly improved patient outcomes worldwide.Missing: Instruments responsibilities
  53. [53]
    3 ways leaders can create a culture of innovation - Boston Scientific
    Oct 30, 2024 · Boston Scientific co-founder John Abele discusses why true innovation requires a company culture, and details how to create a culture of ...
  54. [54]
    Bringing Minds Together - Harvard Business Review
    Bringing Minds Together. by John Abele · From the Magazine (July–August 2011) ... Academic collaboration, I've learned over the years, is something of an ...Missing: lectures ethics science